Researchers discover key stem cell dormancy mechanism which could help unlock future cancer treatments
Researchers have made new findings which provide a broader understanding of how dormant hematopoietic stem cells are activated and could pave the way towards therapeutic treatments for a number of cancers.
Scientists reveal that during hematopoietic regeneration, RNA expressed from a part of the genome considered ‘junk DNA’ is used by hematopoietic stem cells to get activated and proliferate. The study shows that these so-called transposable elements make RNA after chemotherapy and activate an immune receptor which induces inflammatory signals enhancing hematopoietic stem cell cycling and thus participating in the regeneration of the hematopoietic system.
Biomedical engineering researchers developed a new cell classifier tool that takes a higher-resolution look at the life cycle of neuroepithelial stem cells, which led to the discovery and exploration of a new resting phase called Neural G0. This knowledge could help scientists to better understand glioma brain tumors and develop new methods of treatment.
The chances of restoring fertility through sperm stem cell transplant are as random as a coin toss. But a team of scientists developed a new strategy that serves as a ‘weighted coin’ that can favorably rig the odds to achieve outcomes where fertility is successfully restored.
Chemotherapy destroys stem cells, which then cannot develop into immune cells and become part of the body’s defenses. There are drugs that can remedy this, but previously we did not know exactly how these drugs worked. Now, a new study details their function providing new knowledge that may improve stem cell transplantation and lead to better drug design in the future.
Für die Krebsforschung haben Ulmer Wissenschaftlerinnen und Wissenschaftler Bauchspeicheldrüsen-Organoide im Labor gezüchtet. Anhand dieser Modelle aus Stammzellen wollen die Forschenden die Entstehung von Bauchspeicheldrüsenkrebs nachvollziehen. Dadurch erhoffen sie sich neue, patientenspezifische Behandlungsansätze. Zudem könnten diese „duktalen Pankreas-Organoide“ dabei helfen, Tierversuche in der Krebsforschung zu reduzieren. Die aktuelle, in Kooperation mit dem Helmholtz Zentrum in München entstandene Publikation wurde im Journal „Cell Stem Cell“ veröffentlicht.
Der Innsbrucker Molekularbiologe Jerome Mertens und sein Team modellierten erstmals auch die sporadische, nur im Alter auftretende Form von Alzheimer basierend auf Hautzellen von Patient*innen. Die in Cell Stem Cell veröffentlichten Ergebnisse belegen eine Altersabhängigkeit dieser Form der Krankheit und zeigen, dass Alzheimer-Nervenzellen und Krebszellen einiges gemeinsam haben.
DKMS invites medical and healthcare professionals working in hematopoietic stem cell transplantation to visit the newly developed DKMS platform at www.professional.dkms.org. This website gives an overview of the work of all our specialist departments and offers comprehensive insights into the non-profit organization’s scientific studies and publications. Furthermore, it provides access to DKMS’ services, resources, grants and support programs. The site features a modern and streamlined design and makes it easy to access essential information.
Ein Forscherïnnenteam am IMBA – Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften – erforscht an sogenannten Organoiden, wie manche Viren schwere Fehlbildungen im menschlichen Gehirn auslösen können, mit dem Ziel neue Therapieansätze gegen Infektionen und deren Folgen zu entwickeln. Das berichtet das Team rund um Jürgen Knoblich aktuell im Fachmagazin Cell Stem Cell.
As people get older, their neural stem cells lose the ability to proliferate and produce new neurons, leading to a decline in memory function. Researchers at the University of Zurich have now discovered a mechanism linked to stem cell aging – and how the production of neurons can be reactivated.
The gut plays a central role in the regulation of the body’s metabolism and its dysfunction is associated with a variety of diseases, such as obesity, diabetes, colitis and colorectal cancer that affect millions of people worldwide. Targeting endocrine dysfunction by stimulating the formation of specific enteroendocrine cells from intestinal stem cells could be a promising regenerative approach for diabetes therapy. For this, a detailed understanding of the intestinal stem cell lineage and the signals regulating the recruitment of intestinal cell types is critical.
Researchers published promising findings on preventing a common complication to lifesaving blood stem cell transplantation in leukemia.
Immune-system T cells have been reprogrammed into regenerative stem cell-like memory (TSCM) cells that are long-lived, highly active ‘super immune cells’ with strong antitumor activity, according to new research.
Biologists reveal that tissue perturbations by chemotherapy agents promote stem cell expansion and that fibroblast cells exhibit unexpected, immune-like behavior.
Drugs tackling chronic myelogenous leukemia have completely transformed prognoses of patients over the last couple of decades, with most cases going into remission. But drug resistance can occur, leading to relapses. Targeting the lipids involved in regulating part of a leukemia stem cell’s life span offers a potential second route to defeat the disease — and solid tumorous cancers as well.
Researchers have shown by in vitro experimentation that changes of glycans in mouse epidermal stem cells may serve as a biomarker of aging. Further, by overexpression of specific glycogenes in mouse keratinocytes, they replicated the glycome profile of aging cells as well as their decreased proliferation ability. These findings hold promise for stem cell research into skin disorders, specifically senile degeneration, wound healing and skin cancer.
In one of the first studies addressing the role of sex hormones’ impact on stem cells in the gut, scientists outline new insights showing how a steroidal sex hormone, ecdysone, drastically alters the way intestinal stem cells behave, ultimately affecting the overarching structure and function of this critical organ.
Without stem cells, human life would not exist. Due to them, a lump of cells becomes an organ, and a fertilized egg develops into a baby. But what actually makes a stem cell? Are these a stable population of specially gifted cells? Scientists at the Institute of Science and Technology (IST) Austria discovered that instead, stem cells might emerge due to the collective behavior of cells within the organs.
Which pathways govern intestinal epithelial differentiation under constitutive conditions? Epithelial differentiation is largely controlled by the tissue-specific activity of transcription factors. Access to DNA is provided by accessible chromatin (euchromatin), while compacted heterochromatin limits access of transcription factors to DNA. Researchers at the TU Dresden Center for Regenerative Therapies (CRTD) have investigated the significance of the regulation of heterochromatin formation in the intestinal epithelium and published their findings in the renowned international scientific journal Gut.
Many patients with heart disease face limited treatment options. Fortunately, stem cell biology has enabled researchers to produce large numbers of cardiomyocytes, which may be used in drug screens and cell-based therapies. However, current image analysis techniques don’t allow researchers to analyze heterogeneous, multidirectional, striated myofibrils typical of immature cells. Researchers showcase an algorithm that combines gradient methods with fast Fourier transforms to quantify myofibril structures in heart cells.
Mutations in white blood cells can contribute to abnormal immune profile after hematopoietic stem cell transplantation.
A lipid metabolism enzyme controls brain stem cell activity and lifelong brain development. If the enzyme does not work correctly, it causes learning and memory deficits in humans and mice, as researchers at the University of Zurich have discovered. Regulating stem cell activity via lipid metabolism could lead to new treatments for brain diseases.
Researchers at the University of Zurich show that different stem cell populations are innervated in distinct ways. Innervation may therefore be crucial for proper tissue regeneration. They also demonstrate that cancer stem cells likewise establish contacts with nerves. Targeting tumour innervation could thus lead to new cancer therapies.
Cancer cachexia is a complex metabolic disease accounting for approximately one third of all cancer-related deaths worldwide. So far, there is no effective therapy for this muscle wasting disease. Researchers from the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena, Germany, show that the extracellular ligand Wnt7a effectively counteracts muscle wasting through activation of the anabolic AKT/mTOR pathway and thereby reverts the loss of muscle stem cell functionality and muscle mass. The results have now been published in the journal Molecular Therapy: Oncolytics.